Notably, we found that MLL-AF9 leukemia was accelerated in lineage-restricted and global Cxcl12−/− mice, suggesting that CXCL12 expressed by cells in the bone marrow microenvironment restrains AML development. The gene discussed is KMT2A; the disease is acute myeloid leukemia.